All Posts: cancer
-
An Overlooked Hormone Eyed as Deadly Driver of Postmenopausal Breast Cancer in Women with Obesity
A new analysis of research into the most common type of breast cancer has zeroed in on an overlooked hormone that may be responsible for the increased risk of breast cancer death in postmenopausal women with obesity. It also raises the possibility that treatment of these aggressive breast cancers could be improved with the addition of weight-loss drugs known as GLP-1 receptor agonists.
Category: News Release
-
School of Health Student Presents Foundational Cancer Research at International Conference
School of Health student Keerthana Ramanathan (H’26) presented her team’s foundational cancer research at the 37th International Papillomavirus Conference (IPVS) in Bangkok, Thailand, in October. The IPVS is the primary international research conference for human papillomavirus (HPV).
Category: Lombardi Stories
-
Ralph Lauren Center Pastoral Initiative Collaborates with Local Churches to Offer Cancer Education and Screening
Community outreach and engagement is a priority for the Ralph Lauren Center for Cancer Prevention at Georgetown University’s Lombardi Comprehensive Cancer Center, and as its pastoral initiative coordinator, Mireille Bright, PhD, MPH, connects with the leaders of local churches to offer cancer prevention education, screening and navigation services.
Category: Lombardi Stories
-
Leading Cancer Research Centers Reinforce Importance of Safe and Effective Human Papillomavirus (HPV) Vaccination To Prevent Cancer
National Cancer Institute (NCI)-Designated Cancer Centers with leading national organizations and the University of Puerto Rico Comprehensive Cancer Center have released a joint statement reinforcing the importance of safe and effective human papillomavirus (HPV) vaccination to prevent cancer. Nationally, HPV vaccination coverage has stagnated and falls short of the national goals.
Category: News Release
-
Clinical Study Deepens Understanding of Mesothelioma and Opens the Door to Potential Treatment Options
People with operable diffuse pleural mesothelioma may benefit from immunotherapy before and after surgery, based on results of a clinical trial exploring the sequence of treatment and the role of surgery for this difficult to treat cancer.
Category: News Release
-
Rate of Rare Liver Cancer High Among Russian Nuclear Workers, Particularly Women, Study Finds
A new study of Russian nuclear workers, one of only a few to examine liver cancer in people exposed to radiation in a chronic, low-dose occupational setting, finds higher rates of bile duct cancer and hepatocellular carcinoma among the workers, as well as unusually high rates in women of angiosarcoma of the liver, a form of cancer that is extremely rare.
Category: News Release
-
Georgetown Study Highlights Opportunities for Liver Cancer Interventions in Thailand
Safer pesticide practices, clean drinking water, and effective community health programs could help reduce liver and bile duct cancer risk in Thailand, according to a new study by researchers at Georgetown’s Lombardi Comprehensive Cancer Center.
Category: News Release
-
Celebrating a Milestone in Cancer Research
This month marks the 50th anniversary of the publication of a paper by now-Georgetown Lombardi member Marc E. Lippman, MD, MACP, FRCP, and his colleague Gail Bolan, MD, that showed for the first time that the hormone estrogen can drive the growth of breast cancer. It was a pivotal moment in cancer research that has led to life-extending and lifesaving treatments for the thousands of people who develop breast cancer each year.
Category: Lombardi Stories
-
Georgetown Faculty Share Research and Explore Collaborations on Global Cervical Cancer
In June 2025, the Global Cancer Collaborative, a joint initiative between the Georgetown University Global Health Institute and Georgetown Lombardi, hosted a seminar on cervical cancer. Three presenters from Georgetown, including Lombardi member Alejandra Hurtado de Mendoza, PhD, detailed their current work, and attendees from across the university were invited to discuss new opportunities for interdisciplinary collaboration.
Category: Lombardi Stories
-
Rise in Claim Denial Rates for Cancer-Related Advanced Genetic Testing
A newly published analysis by Georgetown Lombardi member So-Yeon Kang, PhD, MBA, and colleagues has found that both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national coverage determination that established coverage standards for NGS testing. Read more about this research.
Category: News Release